Clinical Trial: Pycnogenol for the Treatment of Lymphedema
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Treatment of Arm Lymphedema in Breast Cancer Survivors: A Double-Blind, Randomized Study of Pycnogenol vs. Placebo
Brief Summary: The objectives of this study are to evaluate the effectiveness of Pycnogenol (French maritime pine bark extract) for arm lymphedema in women following treatment for breast cancer, to evaluate the accuracy and sensitivity of bioelectric impedence as a measurement of lymphedema of the arm, and to validate the proposed arm lymphedema quality-of-life questionnaire.
Detailed Summary:
Sponsor: University of Wisconsin, Madison
Current Primary Outcome: reduction of arm lymphedema [ Time Frame: monthly ]
Original Primary Outcome: reduction of arm lymphedema
Current Secondary Outcome: comparison/validation of bioelectric impedance to measure lymphedema changes, validation of lymphedema questionnaire [ Time Frame: monthly ]
Original Secondary Outcome: comparison/validation of bioelectric impedance to measure lymphedema changes, validation of lymphedema questionnaire
Information By: University of Wisconsin, Madison
Dates:
Date Received: September 13, 2005
Date Started: May 2002
Date Completion:
Last Updated: October 1, 2015
Last Verified: January 2008